EF
ELV icon

Empowered Funds’s Elevance Health ELV Stock Holding History

Empowered Funds’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
53,343
+30,442
+133% +$11.3M 0.11% 187
2026
Q1 		$6.7M Buy
+22,901
New +$7.53M 0.04% 526
2025
Q4 		– Sell
-64,471
Closed -$20.8M – 1265
2025
Q3 		$20.8M Sell
64,471
-23,958
-27% -$7.45M 0.21% 83
2025
Q2 		$34.4M Buy
88,429
+72,074
+441% +$29M 0.39% 33
2025
Q1 		$7.11M Sell
16,355
-45,517
-74% -$18.3M 0.1% 275
2024
Q4 		$22.8M Buy
61,872
+19,907
+47% +$8.33M 0.33% 39
2024
Q3 		$21.8M Buy
41,965
+8,379
+25% +$4.48M 0.34% 35
2024
Q2 		$18.2M Sell
33,586
-245
-0.7% -$130K 0.31% 41
2024
Q1 		$17.5M Buy
33,831
+26,733
+377% +$13.3M 0.32% 49
2023
Q4 		$3.35M Sell
7,098
-4,723
-40% -$2.18M 0.08% 346
2023
Q3 		$5.15M Buy
11,821
+7,171
+154% +$3.25M 0.15% 171
2023
Q2 		$2.07M Buy
4,650
+762
+20% +$352K 0.07% 381
2023
Q1 		$1.79M Buy
3,888
+403
+12% +$192K 0.11% 220
2022
Q4 		$1.79M Buy
3,485
+480
+16% +$244K 0.12% 191
2022
Q3 		$1.36M Buy
3,005
+157
+6% +$75.1K 0.13% 146
2022
Q2 		$1.37M Sell
2,848
-3,891
-58% -$1.92M 0.18% 148
2022
Q1 		$3.31M Buy
6,739
+5,060
+301% +$2.31M 0.36% 94
2021
Q4 		$778K Buy
+1,679
New +$706K 0.09% 175
2021
Q3 		– Sell
-10,526
Closed -$4.02M – 225
2021
Q2 		$4.02M Buy
10,526
+1,651
+19% +$631K 0.51% 66
2021
Q1 		$2.85M Hold
8,875
– – 0.55% 39
2020
Q4 		$2.85M Sell
8,875
-1,779
-17% -$546K 0.55% 39
2020
Q3 		$2.86M Buy
10,654
+1,330
+14% +$358K 0.89% 31
2020
Q2 		$2.45M Buy
+9,324
New +$2.49M 0.95% 41
2019
Q4 		– Sell
-8,234
Closed -$1.98M – 118
2019
Q3 		$1.98M Buy
+8,234
New +$2.26M 0.86% 43
2018
Q1 		– Sell
-10,138
Closed -$2.28M – 100
2017
Q4 		$2.28M Buy
10,138
+919
+10% +$196K 1.14% 32
2017
Q3 		$1.75M Buy
+9,219
New +$1.75M 1.14% 38

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Empowered Funds's ELV Position: Q2 2026 in Review

Empowered Funds increased its Elevance Health (ELV) stake by 133% in Q2 2026, buying an estimated $11.3M and bringing the position to 53,343 shares worth $20.6M. The position accounts for 0.11% of the portfolio, ranked #187.

Empowered Funds first reported a position in ELV in Q3 2017 and has held it in 26 quarters since. The position peaked at $34.4M in Q2 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Empowered Funds held 53,343 shares of Elevance Health worth $20.6M as of Q2 2026.
  • Empowered Funds bought 30,442 Elevance Health shares in Q2 2026, an estimated $11.3M.
  • Elevance Health made up 0.11% of Empowered Funds's portfolio in Q2 2026, its #187 holding.
  • Empowered Funds first reported a position in Elevance Health in Q3 2017 and has held it in 26 quarters since.
  • Empowered Funds's Elevance Health position peaked at $34.4M in Q2 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.